allosource
-
Regulatory
AlloSource Receives FDA 510(k) Clearance For AceConnex™ Pre-Sutured Fascia For Hip Labral Reconstruction And Augmentation
First pre-sutured fascia allograft designed for hip arthroscopists to help increase surgeon efficiency and reduce operating room time CENTENNIAL, Colo., July…
Read More » -
Biologics
Study on Prochondrix Osteochondral Allograft Published in the Journal of Orthopaedic Surgery Demonstrates Encouraging Outcomes when Used on Isolated Articular Cartilage Defects
CENTENNIAL, Colo., June 29, 2023 /PRNewswire/ — AlloSource®, a leading innovator and manufacturer of cartilage for joint preservation, today announced the Journal of Orthopaedic…
Read More » -
Biologics
AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation In Soft Tissue Reconstruction
CENTENNIAL, Colo., May 25, 2023 /PRNewswire/ — AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and…
Read More » -
Biologics
AlloSource Announces Dean Elliott As New President And CEO
CENTENNIAL, Colo., Oct. 19, 2022 /PRNewswire/ — AlloSource, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products…
Read More » -
Biologics
AlloSource®Adds Quadricep Tendons To Its AlloConnex™ Line Of Tendons, Ligaments And Fascia
CENTENNIAL, Colo., July 12, 2022 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue…
Read More » -
Biologics
ALLOSOURCE®Announces New Micro Fibers Demineralized Bone Allograft
AlloFuse® Micro Fibers are the latest addition to the company’s AlloFuse line of Fibers and Fiber Boat products, expanding its…
Read More » -
Biologics
Allosource’s Cartilage Allograft Expertise to be Featured at the International Cartilage Regeneration & Joint Preservation Society Annual Meeting
CENTENNIAL, Colo., April 5, 2022 /PRNewswire/ — AlloSource®, one of the largest allograft providers creating innovative cellular and tissue allografts to help surgeons…
Read More » -
Biologics
AlloSource Launches Allomend Extra-large Acellular Dermal Matrix
New dermal graft has the largest footprint within the AlloMend product line to support demanding soft tissue applications in plastic…
Read More » -
Biologics
AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix
New allograft is the thickest in the AlloMend product line to support demanding soft tissue applications CENTENNIAL, Colo., Aug. 11, 2021 /PRNewswire/…
Read More » -
Biologics
AlloSource Announces First Patients Implanted With AlloWrap Amniotic Membrane In Clinical Study For Two-Level Anterior Cervical Discectomy And Fusion Procedures
CENTENNIAL, Colo., Feb. 23, 2021 /PRNewswire/ –AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
AlloSource’s ProChondrix CR, Cryopreserved Osteochondral Allograft, To Be Featured At The British Patellofemoral Society Meeting
CENTENNIAL, Colo., Jan. 15, 2021 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research
CENTENNIAL, Colo., Dec. 8, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products…
Read More » -
Sports Medicine
AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee
CENTENNIAL, Colo., Nov. 17, 2020 /PRNewswire/ –AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
AlloSource® Names Tendon And Ligament Portfolio Under New Brand AlloConnex™
CENTENNIAL, Colo., July 23, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts…
Read More » -
Biologics
Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years
CENTENNIAL, Colo., Oct. 7, 2019 /PRNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More »